PIPERAZINE CITRATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for piperazine citrate and what is the scope of patent protection?

Piperazine citrate is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Sanofi Aventis Us, Bluline, Alpharma Us Pharms, Lannett, Luitpold, Solvay, and Impax Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	BRYREL	piperazine citrate	SYRUP;ORAL	017796-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bluline	MULTIFUGE	piperazine citrate	SYRUP;ORAL	009452-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Luitpold	PIPERAZINE CITRATE	piperazine citrate	SYRUP;ORAL	080671-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	PIPERAZINE CITRATE	piperazine citrate	SYRUP;ORAL	080774-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Solvay	VERMIDOL	piperazine citrate	SYRUP;ORAL	080992-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glaxosmithkline	ANTEPAR	piperazine citrate	SYRUP;ORAL	009102-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	5
Applicants:	8
NDAs:	8
Raw Ingredient (Bulk) Api Vendors:	54
Patent Applications:	48
DailyMed Link:	PIPERAZINE CITRATE at DailyMed